Processa Pharmaceuticals Cash from Financing (TTM) Analysis

Processa Pharmaceuticals Inc (PCSA)

1.67 +0.13 (+8.44%) USD | NASDAQ | Apr 17, 16:00

1.66 -0.01 (-0.60%) After-Hours: 05:39

Cash from Financing (TTM) Chart

Historical Cash from Financing (TTM) Data

View and export this data back to 2012. Upgrade now.

Date	Value
December 31, 2023	6.269M
September 30, 2023	6.246M
June 30, 2023	6.263M
March 31, 2023	6.263M
December 31, 2022	-0.3888M
September 30, 2022	-0.2039M
June 30, 2022	-0.3538M
March 31, 2022	-0.3769M
December 31, 2021	9.799M
September 30, 2021	27.03M
June 30, 2021	27.06M
March 31, 2021	27.75M
December 31, 2020	17.87M
September 30, 2020	1.302M
June 30, 2020	1.963M
March 31, 2020	1.583M
December 31, 2019	1.701M
September 30, 2019	0.6807M
June 30, 2019	0.2857M
March 31, 2019	2.739M
December 31, 2018
September 30, 2018
June 30, 2018

Date	Value
March 31, 2018
December 31, 2017	2.425M
September 30, 2017	0.327M
June 30, 2017	0.075M
March 31, 2017	0.00
December 31, 2016	0.015M
September 30, 2016	0.015M
June 30, 2016	0.0621M
March 31, 2016	0.3121M
December 31, 2015	0.8211M
September 30, 2015	1.269M
June 30, 2015	1.788M
March 31, 2015	2.205M
December 31, 2014	2.575M
September 30, 2014	1.781M
June 30, 2014	2.316M
March 31, 2014	2.632M
December 31, 2013	1.732M
September 30, 2013	2.370M
June 30, 2013	1.430M
March 31, 2013	0.4466M
December 31, 2012	0.4534M

Cash From Financing Definition

Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.

Read full definition.

Cash from Financing (TTM) Range, Past 5 Years

-0.3888M

Minimum

Dec 2022

27.75M

Maximum

Mar 2021

7.407M

Average

1.963M

Median

Jun 2020

Cash from Financing (TTM) Benchmarks